Tokyo, June 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061586) titled 'Effect of synbiotics intake on intestinal environment and gut microbiota' on May 31.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Pharmaceutical Research Department, Yakult Central Institute
Condition:
Condition - Not applicable
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the effects of intervention of synbiotics on gut microbiota and intestinal environment.
Basic objectives2 - Others
Intervention:
Interventions/Control_1 - Four week intervention of synbiotics (Three times per day)
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Subjects having an ability to understand study purpose and detail with voluntary written informed consent.
Key exclusion criteria - Dairy allergy
Target Size - 20
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2025 Year 07 Month 21 Day
Date of IRB - 2025 Year 08 Month 21 Day
Anticipated trial start date - 2025 Year 09 Month 29 Day
Last follow-up date - 2025 Year 11 Month 26 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070459
Disclaimer: Curated by HT Syndication.
